Laser for Fertility Success

Those who have met me know laser for fertility has become a passion of mine and I am guilty of purchasing or renting more laser systems to add to your acupuncture treatments to make sure we leave no stone unturned when it comes to helping you reach your peak fertility. ~ Dr Lorne Brown

VANCOUVER, British Columbia (PRWEB)
November 23, 2021

There have been a lot of advancements in the field of low level laser therapy (LLLT) for fertility since Acubalance introduced laser acupuncture to maximize egg quality and improve IVF success back in late 2008.

Low-level laser therapy (LLLT) for fertility, referred to as photobiomodulation (PBM) for fertility by the scientific community, may sound like futuristic medicine but the unique treatment has been shown to boost fertility and increase IVF success.

Recent studies are showing that combining acupuncture and LLLT with fertility treatments such as in-vitro fertilization (IVF) can increase live births and improve health outcomes for moms and babies, as well for women diagnosed with PCOS, endometriosis, and unexplained infertility.

In addition to supporting IVF, the fusion of acupuncture and LLLT treatments can provide several other benefits:

1) Increases mitochondria function and ATP production (recharges the battery of the cell to help maximize egg and sperm quality)

Adenosine triphosphate (ATP), cellular energy, plays an essential role in fertility as it provides the egg cells with the energy required to divide and the embryo to divide and implant. Laser acupuncture treatments can increase the amount of ATP that your cells produce with the goal to maximize egg quality so there is adequate energy needed for the embryo to divide (whether in your tube & uterus or in the IVF lab) and for the energy required for implantation.

Laser acupuncture onsite at the IVF clinic on the day of embryo transfer increased implantation rates by 15% in one study.

2) Regulates inflammation

If you have systemic inflammation, this could be decreasing your chances of getting pregnant. A woman diagnosed with endometriosis, PCOS, or unexplained infertility can optimize their fertility by regulating inflammation with a series of LLLT treatments, antioxidant supplements, and following the Acubalance anti-inflammatory fertility diet

3) Improves blood circulation

Becoming pregnant can be very difficult for women with poor or obstructed blood circulation. Improving your blood circulation can greatly benefit your ovaries and uterine receptivity. As a woman ages, the blood to her reproductive organs declines. When a cell is deprived of circulation it can lead to discomfort and cell death, so blood flow and microcirculation are essential for cellular health, and this includes sperm and egg cells.

Photobiomodulation improves your blood circulation and lymphatic flow to optimize fertility. More blood flow to the ovaries means more nutrients, oxygen, hormones, and fertility medications can reach your follicles to support the eggs’ need for optimal growth and quality and the uterus is more receptive for implantation and provides the optimal environment for the length of the pregnancy.

4) Decreases stress and promote parasympathetic function

Unfortunately, stress and infertility often go hand-in-hand. Stress hormones like epinephrine and cortisol can negatively impact blood sugar hormones and the flow of blood to your ovaries and uterus as well cause the time to pregnancy to slow down based on studies. Regulating blood sugar & stress hormones as well as increasing blood flow to the ovaries and uterus by promoting your body’s parasympathetic function through Low-level laser therapy (LLLT) for fertility can be beneficial.

5) Speeds tissue healing

Healing damaged tissues and softening scarring or adhesions can improve fertility outcomes. Scar tissue from previous surgeries or infections can collect around one’s reproductive organs and become problematic if left unaddressed.

6) Improves Gut Microbiome

The health of the gut microbiome can have a systemic effect on health and fertility. The microbiome has been linked to

Skin conditions (eczema, psoriasis, and rosacea)

Gut health (inflammatory bowel disease)

Mental health (depression and anxiety)

Autoimmune Diseases

Allergies

Obesity

Dementia & Alzheimer’s disease and Parkinson’s

There has been an association between the uterine microbiome and implantation failure so now the scientific community is wondering if the gut microbiome can impact the vaginal and uterine environment. While studies continue to determine if there is any connection, Acubalance recommends being proactive and balancing the microbiome since it can have such an impact on overall well-being. There are published studies on using low-level laser therapy (photobiomodulation) to treat the gut microbiome and seeing positive clinical outcomes with Parkinson’s patients.

7) Change brain altered states for mood, focus, and increased libido

More recently photobiomodulation to the brain has been used for dementia, anxiety, PTSD, Parkinson’s, Alzheimer’s, and altered conscious states. There is even a study demonstrating increased libido. When couples are TTC then it is known infertility can dampen libido and lead to feeling down and depressed. Acubalance is currently adding laser for mood and libido enhancement to fertility patients and although it has been a handful of people, they have expressed an increase in mood following their treatments.

To learn more about laser for fertility click here

Share article on social media or email:

There is no doubt that collection of basic information related to sexual orientation and gender identity improves the experiences of sexual and gender minorities in healthcare settings.

BOSTON (PRWEB)
November 23, 2021

A paper published in Nature Medicine outlines the ways in which electronic health records can be used as a tool to reduce health disparities affecting LGBTQIA+ people. The paper is part of Nature Medicine’s “Series on Diversity, Equity and Inclusion,” and anchors the journal’s reporting on how lack of diversity in medical research data affects patient populations. Authored by Dr. Alex S. Keuroghlian, who directs the National LGBTQIA+ Health Education Center at The Fenway Institute and the Massachusetts General Hospital Psychiatry Gender Identity Program, the paper details how sexual orientation and gender identity (SOGI) data collection can improve patient and community care and offers actionable ways to implement SOGI data collection in healthcare settings.

“There is no doubt that collection of basic information related to sexual orientation and gender identity improves the experiences of sexual and gender minorities in healthcare settings,” said Keuroghlian. “But most clinicians do not discuss sexual orientation or gender identity with their patients out of concern about causing patient discomfort or offense, because they are unaware that this information is relevant to patient care.”

The paper, titled “Electronic health records as an equity tool for LGBTQIA+ people,” demonstrates that collecting SOGI data can reduce clinical errors and insurance reimbursement denials for necessary interventions and preventative screenings, such as failing to offer or pay for routine cervical Pap tests with trans masculine patients who retain a cervix. Collecting SOGI data also provides clinicians with information that they can then use to proactively address issues relevant to sexual and gender minority patients, such as offering effective advice on how to maintain sexual health during the pandemic or reduce risk for HIV transmission.

Healthcare organizations that collect and analyze SOGI data have identified disparities based on sexual orientation, gender identity, or both, in screening rates among patients for cervical cancer, depression, and tobacco use. In addition to identifying and addressing these disparities, other examples of the ways in which collecting and analyzing SOGI data may advance LGBTQIA+ health equity including the following:

• 
  Helping to understand and reduce disparities related to SARS-CoV-2 in testing, infection, outcomes, and vaccination among sexual and gender minority populations experiencing adverse social determinants of health.
• Incorporating gender identity data collection during isotretinoin prescription registration for treating severe acne could prevent teratogenicity among people who can become pregnant and do not identify as female.

Implementing SOGI data collection can begin by inclusively revising language in the forms that patients are asked to fill out and by training patient-facing staff and clinicians in how to inclusively address patients.

“All healthcare staff should be required to have training to mitigate the adverse impact of implicit bias against sexual and gender minority patients and clinician education ought to emphasize mastery of basic concepts related to sexual orientation, gender identity and sex development, how to sensitively and effectively communicate with LGBTQIA+ patients, and how to build inclusive and affirming healthcare environments for LGBTQIA+ communities,” added Keuroghlian.

To advance SOGI data collection throughout systems of healthcare research, treatment, and prevention, people with diverse sexual orientations, gender identities, and sex development should be recruited and financially compensated for work in EHR-related technology, protocols, and policy design.

“Community advisory boards that influence organizational leadership and service delivery ought to include LGBTQIA+ people,” said Keuroghlian. “They should also be included on medical coding boards that inform administrative classification and billing for health services and hold meaningful positions in health data standards development organizations, such as the Health Level Seven International Gender Harmony Project.”

“Electronic health records as an equity tool for LGBTQIA+ people” is available online. It is the latest in a series of papers by Fenway Health-affiliated scientists, researchers, and clinicians that study ways to advance LGTQIA+ health equity. Other recent papers include “Still in the Dark Regarding the Public Health Impact of COVID-19 on Sexual and Gender Minorities,” published in the American Journal of Public Health; “Organizational Strategies and Inclusive Language to Build Culturally Responsive Health Care Environments for Lesbian, Gay, Bisexual, Transgender, and Queer People,” published in the Journal of Health Care for the Poor and Underserved; and “City-level Structural Stigma and Patient Sexual Orientation and Gender Identity Data Collection at U.S. Health Centers, 2018,” published in the American Journal of Public Health.

Founded in 1971, Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.

The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

Share article on social media or email:

Viewpoint will highlight Vivid Vision’s virtual reality software that is helping vision care professionals around the world manage patients with binocular vision dysfunctions such as convergence insufficiency, lack of stereo depth perception, and amblyopia (lazy eye).

MIAMI (PRWEB)
November 23, 2021

Vivid Vision will be showcased on the award-winning educational series Viewpoint with Dennis Quaid. The show depicts the stories of industry-leading organizations. The Vivid Vision segment of Viewpoint with Dennis Quaid is scheduled for distribution to participating stations on November 22nd, with a twelve-month option for circulation. Additionally, Vivid Vision commissioned a high-end commercial segment which aired nationally on Fox Business Network on November 16th and will continue to air regionally throughout the month of November in the top 100 US media markets on networks such as CNBC, MSNBC, CNN, CNN Headline News, and others.

Viewpoint will highlight Vivid Vision’s virtual reality software that is helping vision care professionals around the world manage patients with binocular vision dysfunctions such as convergence insufficiency, lack of stereo depth perception, and amblyopia (lazy eye). Over 40,000 patients worldwide have used the Vivid Vision system as part of their vision therapy programs.

The Vivid Vision Viewpoint segment also features Dr. Dan Fortenbacher and the team from WOW Vision Therapy in Grand Rapids, Michigan. Dr. Fortenbacher’s team uses Vivid Vision in their in-office and remote vision therapy programs. One of WOW’s patients, Hanah VanderMeulen, shares briefly about how strabismus impacted her life and about her successful vision therapy journey thanks to WOW Vision Therapy and their experienced team of optometrists and vision therapists.

Binocular vision problems like amblyopia (lazy eye) and strabismus (crossed eye) affect more than 1 in 20 people. Many are either unaware they have a binocular vision problem or have been told there are no options available for them. Vivid Vision’s virtual reality vision therapy platform provides a powerful vision training tool for helping these patients.

About Viewpoint with Dennis Quaid

As a unique, educational platform, Viewpoint with Dennis Quaid consists of short-form Public Television stories that cover a wide range of issues and topics. The award-winning series has featured a variety of the world’s most influential organizations.

Host Dennis Quaid has an array of film and television credits as an actor, director, producer and Golden Globe nominee. Quaid has been featured in numerous box office hits from “Any Given Sunday” to “Vantage Point.”

About Vivid Vision

Vivid Vision Clinical is a virtual reality-based vision training platform. It is designed to let your eye doctor have absolute control over your vision training. For less complex cases, for patients who can’t make it into the clinic as often as they should, or as an adjunct/follow-up vision training system, there’s Vivid Vision Home. The company is focused on improving the patient experience and making vision care solutions more accessible. Vivid Vision is headquartered in San Francisco with employees across the country and distributor partners across the globe.

For media inquiries, please contact: media@seevividly.com

To find a vision therapy provider offering Vivid Vision near you: http://www.seevividly.com/doctor_locator

Link to video segment: https://www.seevividly.com/viewpoints

Share article on social media or email:

Intech & Coulot join forces to help orthopedic companies

Because of our shared passion for quality and customer service, we are thrilled to welcome Coulot as part of our family.

MEMPHIS, Tenn. (PRWEB)
November 23, 2021

Intech announced today that it has entered an exclusive agreement to acquire Coulot Decolletage, expanding the group’s expertise into the machining and additive manufacturing of high-precision medical implants for the Spine, Extremity, and Trauma segments of the Orthopedic market.

Coulot was founded in 1985 and has earned its reputation by producing high precision medical implants and expanding their know-how into 3D-printing.

This milestone transaction marks the first acquisition in the wake of Montagu’s recent investment in Intech. It is designed to take Intech’s value proposition to the next level, while reinforcing the quality of services provided to Medical Device companies. The partnership with Coulot expands the Intech’s Group footprint into orthopedics implants and jump-starts the group’s journey into additive manufacturing.

“We are excited to become a part of Intech Group. Delivering best-in-class customer service and helping patients get taken care of is what we are about. It’s exciting that the partnership with Intech allows us to do what we do on a much larger scale.“ Bruno Coulot, General Manager of Coulot Decolletage

Coulot Decolletage underwent a series of major investments in recent years to develop state-of-the-art processes. The vertically integrated facility is setup to manufacture a wide array of implants from titanium nails, plates and screws to PEEK and 3D-printed cages. The newly consolidated group is expected to generate over $150M in revenue in FY 2021.

“Because of our shared passion for quality and customer service, we are thrilled to welcome Coulot as part of our family. This latest integration makes a lot of sense. It allows us to keep enhancing our relationship with our customers by providing them with a single-source solution, from 3D-printing of implants to kitting of instruments.“ Laurent Pruvost, President & CEO of Intech

For more information on this acquisition, call us or visit intech-medical.com.

About Coulot

A family enterprise founded in 1985 in Châtellerault, France. The customer-driven company has been supporting major Medical Device companies worldwide by manufacturing complex implants and medical prostheses for Spine, Extremity and Trauma. Coulot Décolletage innovates and offers additive manufacturing services to support its customer’s your most audacious 3D printing designs. For additional information on Coulot, visit http://www.coulot-decolletage.com

About Intech

A global player in the orthopedics market, Intech delivers unique solutions that better patients’ lives around the world. Founded in 2000, the Group is proud to lead the way in the manufacturing of surgical instruments and implants, cases & trays, and silicone handles. Powered by 900 Intechers across the United States, France and Malaysia, Intech is a premiere engineering powerhouse, capable of delivering manufacturing solutions anywhere, at any time. For additional information on Intech, visit http://www.intech-medical.com

Share article on social media or email:

BreatheMD wins Taste for Life’s ‘Immunity Essentials Award’

Empowering people to live healthier lives is the best reward we could ever receive, and this award from Taste for Life affirms that we are fulfilling our mission.” said Ziv Haklili, Co-Founder of 1MD Nutrition and Scale Media

LOS ANGELES (PRWEB)
November 23, 2021

1MD Nutrition™, a premium, physician-formulated nutritional supplements brand owned by Scale Media, has added to a growing portfolio of awards with its BreatheMD™ product recognition. A trusted industry source for natural supplements in health and wellness, Taste for Life awarded BreatheMD the 2021 ‘Immunity Essentials Award’ in the Lung Support category. A comprehensive lung and respiratory support supplement, BreatheMD promotes antioxidant activity, respiratory system performance, immune system defenses, and better overall health. It combines South African Geranium, a break-through traditional herb known to help promote a healthy immune system and support proper lung function, with an additional eight botanicals, vitamins, minerals, and an amino acid.

BreatheMD was developed by 1MD Nutrition’s product scientists in response to the increasing need to support lung and respiratory health in the United States, with a one-of-a-kind immunity and respiratory formula promoting lung function support. BreatheMD is recommended by Dr. Brian Greenberg, 1MD Nutrition’s Immunologist with nearly 30 years helping patients of all ages maintain their respiratory and immune health.

“In my opinion 1MD Nutrition has developed a truly unique immune and respiratory system supplement,” said Dr. Greenberg. “It contains proper dosages of African geranium, elderberry, L-cysteine, vitamin D, and vitamin C, that are complemented by the recommended daily allowance of zinc and chromium formulated to promote proper lung function, support and maintain the body’s proper immune response, and help your body protect itself from seasonal threats.”

BreatheMD’s Taste for Life 2021 Immunity Essentials Award comes on the heels of 1MD’s Nutrition’s previous award for its LiverMD supplement, supporting the brand’s expanded mission to help people live longer, healthier lives through the powerful integration of advanced science and nature.

“Empowering people to live healthier lives is the best reward we could ever receive, and this award from Taste for Life affirms that we are fulfilling our mission.” said Ziv Haklili, Co-Founder of 1MD Nutrition and Scale Media. “These awards are also a testament to our dedication to continual review of new research on the latest technology, ingredient innovations, and consumer feedback to ensure our supplements provide real, powerful results.”

To learn more about BreatheMD, visit 1md.org/product/breathemd.

About Scale Media:

Headquartered in Los Angeles, California, Scale is a tech-driven direct-to-consumer company that builds and deploys next-generation CPG brands in the beauty, health and wellness industries. Through their proprietary eCommerce and digital marketing engine, Scale transforms consumers’ end-to-end online shopping experience while increasing brand loyalty and retention. Founded in 2013 by serial entrepreneurs Ben Flohr and Ziv Haklili, the company has rapidly powered and scaled concepts into multi-million-dollar consumer lifestyle brands, including 1MD Nutrition, Hair La Vie, Simple Beauty, Live Conscious, Tru Alchemy and Essential Elements. Today, Scale’s growing portfolio of 70+ products helps hundreds of thousands of people live healthier lives. The company is recognized as a Forbes’ Best Startup Employer for 2020, and is the 2020 recipient of the NBJ Leadership & Growth Award. Learn more about Scale and their house of brands at ScaleMedia.com.

Scale Inquiries: Nicole Khandhar, nicole.k@scale.tech

1MD Nutrition Inquiries: Jennifer Fontaine, jen.f@scale.tech

Share article on social media or email:

“For The Old Wolf Supplements, this ClearAngel investment will help bring their innovative approach to canine wellness to exponentially more dogs around the world,” said Andrew D’Souza, CEO and co-founder, Clearco.

TORONTO (PRWEB)
November 23, 2021

Clearco, the world’s largest e-commerce investor revolutionizing the way founders grow their businesses, today announced that its industry-leading ClearAngel program is funding The Old Wolf Supplements, a performance supplement company for dogs with a mission to encourage dog owners to be more active with their faithful companions. ClearAngel gives early-stage companies access to revenue share capital, data-driven advice, and an extensive network of apps, agencies, and investors powered by Clearco.

Founded in 2018, The Old Wolf Supplements is one of the first companies in the world of dog sport to offer a range of performance supplements in order to improve muscular development, recuperation after effort and especially dog health. Trained as an active Canicross runner, founder Shawn Beaulieu is an expert on the types of high-energy food and supplements dogs need to maintain their liveliness and energy for years. He shares this expertise not only in supplements but also by using The Old Wolf Supplements as a platform to provide tailored advice for dog owners to achieve their wanted goals.

The Old Wolf Supplements have reached great success in their sales but are interested in scaling their business to the next level. ClearAngel’s investment will help the company to recruit an impressive advertising team to reach their goal of $20,000 in sales per month. ClearAngel is among just a few equity-free, flexible capital options for early-stage founders who lack the network to raise an angel round or join exclusive accelerators. Since its February 2021 launch, the program has already funded over 350 companies.

“We’re excited to fund The Old Wolf Supplements in its mission to support the health and growth of dogs worldwide,” said Andrew D’Souza, CEO and co-founder, Clearco. “For The Old Wolf Supplements, this ClearAngel investment will help bring their innovative approach to canine wellness to exponentially more dogs around the world.”

In addition to $10,000 of flexible capital, The Old Wolf Supplements will also get access to a network of more than 500 investors, growth teams, agencies, apps, lawyers, and buyers; and data-driven advice designed to help scale and hit new revenue milestones.

“Having access to ClearAngel’s impressive network has already kickstarted the company into thinking about the most strategic ways to grow,” said Shawn Beaulieu, Founder, The Old Wolf Supplements. “We are dedicated to encouraging dog owners around the world to be more active with their canine companions and we’re excited to bring our products to a whole new market​​.”

To learn more about The Old Wolf Supplements and experience their products for yourself, visit theoldwolfsupplements.com.

ClearAngel is currently onboarding E-commerce and product companies. The program has limited spots available for SaaS, Apps, marketplace and stealth companies. To learn more about applying, visit angel.clearbanc.com.

About Clearco:

Co-founded as Clearbanc in 2015 by Michele Romanow from Canada’s Shark Tank (Dragons’ Den), Andrew D’Souza, Ivan Gritsiniak, Charlie Feng, and Tanay Delima, Clearco offers the most founder-friendly capital solutions for e-commerce, mobile apps, and SaaS founders as well as a full suite of products and access to a powerful global network, insights and data, and recommendations. Clearco has invested over $2 Billion in over 4,500 companies to date, including Leesa Sleep, fashion-rental service Le Tote, home goods company Public Goods, shirtmaker UNTUCKit, online speech therapy practice Expressable, and digital real estate marketplace SetSchedule. For more information visit clear.co and @getClearco.

Share article on social media or email:

“Many Jumpstart participants were able to greatly reduce or even eliminate use of medications upon completion of the program.”

ST. LOUIS (PRWEB)
November 23, 2021

The American College of Lifestyle Medicine (ACLM) today announced that the Rochester Lifestyle Medicine Institute (RLMI) Jumpstart Program has earned Certified Lifestyle Medicine Program designation. The designation recognizes, supports and encourages adoption of evidence-based health intervention programs that meet rigorous review requirements and standards for offering lifestyle modification for chronic disease treatment and reversal.

Jumpstart, led by Founder and President of the Rochester Lifestyle Medicine Institute, Ted Barnett, MD, FACLM, DipABM, helps participants prevent, arrest and even reverse chronic disease such as heart disease, type 2 diabetes and high blood pressure through a scientifically proven whole-food, plant-based approach to eating. The 15-day program features interactive large and small group discussions on Zoom with medical providers, and has shown measurable success helping individuals improve their weight, blood pressure, total and LDL cholesterol and fasting glucose.

Many Jumpstart participants were able to greatly reduce or even eliminate use of medications upon completion of the program. In June, the Rochester Lifestyle Medicine Institute announced it would expand the program to all of North America and internationally.

Jumpstart has earned praise among leaders in the field of lifestyle medicine, including Caldwell B. Esselstyn, Jr., MD, director of the Heart Disease Reversal Program at the Cleveland Clinic, who said “The Rochester Lifestyle Medicine Institute has created an educational program founded on evidence-based science, proven to prevent, treat, and reverse chronic disease. Participants will readily comprehend the science that will empower them as the locus of control to achieve the goal of lifelong optimal disease-free health.”

Lifestyle medicine is defined as the use of evidence-based lifestyle therapeutic intervention—including a whole-food, plant-predominant eating pattern, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection—as a primary modality, delivered by clinicians trained and certified in this specialty, to prevent, treat, and often reverse chronic disease.

The ACLM program certification designation is offered at three different levels based upon evaluation scores—Honorable Mention, Certified and Gold Certified. The levels are based on factors including years in operation, number of participants, number of organizations using the program, inclusion of all lifestyle medicine pillars, intervention trials, duration of active treatment, amount of staff contact and follow-up, positive health metrics achieved and participant testimonials.

“ACLM is excited to recognize Rochester Lifestyle Medicine Institute’s 15-Day WFPB Jumpstart as a Certified Lifestyle Medicine Program,” said ACLM President Cate Collings, MD, MS, FACC, DipABLM. “Jumpstart gives participants the knowledge, tools and motivation they need to completely change their lives through a scientifically proven whole-food plant-based approach to eating.”

ABOUT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE: ACLM is the medical professional society for those dedicated to the advancement and clinical practice of lifestyle medicine as the foundation of a transformed and sustainable health care system. Lifestyle medicine is the use of evidence-based lifestyle therapeutic intervention—including a whole-food, plant-predominant eating pattern, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection—as a primary modality, delivered by clinicians trained and certified in this specialty, to prevent, treat, and often reverse chronic disease.

More than a professional association, ACLM is a galvanized force for change. ACLM addresses the need for quality education and certification, supporting its members in their individual practices and in their collective mission to domestically and globally promote lifestyle medicine as the first treatment option, as opposed to a first option of treating symptoms and consequences with expensive, ever increasing quantities of pills and procedures. ACLM members are united in their desire to identify and eradicate the root cause of disease.

ABOUT ROCHESTER LIFESTYLE MEDICINE INSTITUTE:

Rochester Lifestyle Medicine Institute advocates for treating the root causes of lifestyle-based chronic conditions. It is dedicated to educating individuals about the power of a whole-food plant-based diet and its proven ability to heal the body from within.

Share article on social media or email: